M B Holmes1, S Kabbani, M W Watkins, R W Battle, D J Schneider. Show Affiliations » 1. University of Vermont College of Medicine, Burlington 05401, USA. michael.holmes@vtmednet.org
Abstract
Mesh： See more » AbciximabAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/pharmacologyAntibodies, Monoclonal/therapeutic useAnticoagulants/adverse effectsArtifactsFemaleHeparin/adverse effectsHumansImmunoglobulin Fab Fragments/adverse effectsImmunoglobulin Fab Fragments/pharmacologyImmunoglobulin Fab Fragments/therapeutic useMiddle AgedMyocardial Infarction/bloodMyocardial Infarction/drug therapyPlatelet Aggregation/drug effectsPlatelet Aggregation Inhibitors/adverse effectsPlatelet Aggregation Inhibitors/pharmacologyPlatelet Aggregation Inhibitors/therapeutic usePlatelet Count/drug effectsThrombocytopenia/chemically inducedThrombocytopenia/diagnosis
Substances： See more » Antibodies, MonoclonalAnticoagulantsImmunoglobulin Fab FragmentsPlatelet Aggregation InhibitorsHeparinAbciximab
Year: 2000 PMID： 10694535 DOI： 10.1161/01.cir.101.8.938
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690